Mary Wangen

420 total citations
19 papers, 115 citations indexed

About

Mary Wangen is a scholar working on General Health Professions, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary Wangen has authored 19 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in General Health Professions, 7 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary Wangen's work include Health Policy Implementation Science (10 papers), Colorectal Cancer Screening and Detection (6 papers) and Primary Care and Health Outcomes (5 papers). Mary Wangen is often cited by papers focused on Health Policy Implementation Science (10 papers), Colorectal Cancer Screening and Detection (6 papers) and Primary Care and Health Outcomes (5 papers). Mary Wangen collaborates with scholars based in United States, Sweden and South Africa. Mary Wangen's co-authors include Jennifer Leeman, Catherine L. Rohweder, Sarah A. Birken, Linda K. Ko, Mimi Choy-Brown, Bárbara Baquero, Per Nilsén, Miriam Bender, Stephanie B. Wheeler and Alison T. Brenner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medical Internet Research and Preventive Medicine.

In The Last Decade

Mary Wangen

17 papers receiving 108 citations

Peers

Countries citing papers authored by Mary Wangen

Since Specialization

Citations

This map shows the geographic impact of Mary Wangen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Wangen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Wangen more than expected).

Fields of papers citing papers by Mary Wangen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Wangen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Wangen. The network helps show where Mary Wangen may publish in the future.

Co-authorship network of co-authors of Mary Wangen

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Wangen. A scholar is included among the top collaborators of Mary Wangen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Wangen. Mary Wangen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	It Is a Good Idea, but Are They Willing? Assessing Pharmacist Willingness to Deliver Colorectal Cancer Screening 2025 ·Cancer Epidemiology Biomarkers & Prevention ·Alison T. Brenner, (unknown), Austin R. Waters, Mary Wangen, Macary Weck Marciniak, Renée M. Ferrari, Stephanie B. Wheeler, Parth D. Shah	0
2	Not just about pills: Findings from a national survey of pharmacists to understand their views on addressing social determinants of health 2025 ·Preventive Medicine Reports ·(unknown), Austin R. Waters, Mary Wangen, (unknown), Renée M. Ferrari, Macary Weck Marciniak, Alison T. Brenner, Stephanie B. Wheeler, Parth D. Shah	1
3	Evaluation and lessons learned from the dissemination and implementation science scholars program in the national cancer prevention and control research network 2024 ·Journal of Clinical and Translational Science ·Daniela B. Friedman, Cam Escoffery, Elaine H. Morrato, Cynthia A. Thomson, (unknown), (unknown), Mary Wangen, (unknown), James R. Hébert, (unknown), (unknown), David O. Garcia, Jennifer L. Cruz, Stephanie B. Wheeler	0
4	Findings From a National Survey of Older US Adults on Patient Willingness to Use Telehealth Services: Cross-Sectional Survey 2024 ·Journal of Medical Internet Research ·(unknown), Tamera D. Hughes, Austin R. Waters, Benjamin Y. Urick, (unknown), Mary Wangen, Catherine L. Rohweder, Renée M. Ferrari, Macary Weck Marciniak, Stephanie B. Wheeler, Alison T. Brenner, Parth D. Shah	4
5	How pharmacists would design and implement a community pharmacy-based colorectal cancer screening program 2024 ·SHILAP Revista de lepidopterología ·Austin R. Waters, (unknown), Dana L. Atkins, (unknown), Renée M. Ferrari, Catherine L. Rohweder, Mary Wangen, Rachel M. Ceballos, Rachel B. Issaka, Daniel S. Reuland, Stephanie B. Wheeler, Alison T. Brenner, Parth D. Shah	2
6	A streamlined approach to classifying and tailoring implementation strategies: recommendations to speed the translation of research to practice 2024 ·SHILAP Revista de lepidopterología ·Jennifer Leeman, Catherine L. Rohweder, Jennifer Elston Lafata, Mary Wangen, Renée M. Ferrari, Christopher M. Shea, Alison T. Brenner, (unknown), (unknown), Mark Toles	4
7	Patient Willingness to Use a Pharmacy-Based Colorectal Cancer Screening Service: A National Survey of U.S. Adults 2023 ·Cancer Epidemiology Biomarkers & Prevention ·Parth D. Shah, Mary Wangen, Catherine L. Rohweder, Austin R. Waters, (unknown), Macary Weck Marciniak, Renée M. Ferrari, Stephanie B. Wheeler, Alison T. Brenner	3
8	Twenty years of capacity building across the cancer prevention and control research network 2023 ·Cancer Causes & Control ·Mary Wangen, Cam Escoffery, María E. Fernández, Daniela B. Friedman, Peggy A. Hannon, Linda K. Ko, Annette E. Maxwell, (unknown), Betsy Risendal, Catherine L. Rohweder, Jennifer Leeman	4
9	Mixed methods evaluation of the inaugural year of the Cancer Prevention and Control Research Network’s (CPCRN) scholars program 2023 ·Cancer Causes & Control ·Cam Escoffery, (unknown), Mary Wangen, (unknown), (unknown), (unknown), Cynthia A. Thomson, Elaine H. Morrato, Swann Arp Adams, Jennifer Leeman, Daniela B. Friedman	2
10	Patient perspectives on a proposed pharmacy-based colorectal cancer screening program 2023 ·Translational Behavioral Medicine ·Renée M. Ferrari, Dana L. Atkins, Mary Wangen, Catherine L. Rohweder, Austin R. Waters, (unknown), Jennifer Richmond, (unknown), (unknown), (unknown), Rachel B. Issaka, Rachel M. Ceballos, Parth D. Shah, Stephanie B. Wheeler, Alison T. Brenner	5
11	Patient preferences for the design of a pharmacy-based colorectal cancer screening program 2023 ·Cancer Causes & Control ·Alison T. Brenner, Austin R. Waters, Mary Wangen, Catherine L. Rohweder, (unknown), Macary Weck Marciniak, Renée M. Ferrari, Stephanie B. Wheeler, Parth D. Shah	8
12	Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative study 2023 ·BMC Health Services Research ·Alison T. Brenner, Catherine L. Rohweder, Mary Wangen, Dana L. Atkins, Rachel M. Ceballos, (unknown), Renée M. Ferrari, Rachel B. Issaka, (unknown), (unknown), Daniel S. Reuland, Austin R. Waters, Stephanie B. Wheeler, Parth D. Shah	4
13	Toward a more comprehensive understanding of organizational influences on implementation: the organization theory for implementation science framework 2023 ·Frontiers in Health Services ·Sarah A. Birken, (unknown), (unknown), Michelle C. Kegler, Jure Baloh, Prajakta Adsul, María E. Fernández, (unknown), Terry T.‐K. Huang, Matthew Lee, Mary Wangen, (unknown), Miriam Bender, Mimi Choy-Brown, Grace Ryan, (unknown), Linda K. Ko	3
14	Increasing Access to Organization Theories for Implementation Science 2022 ·Frontiers in Health Services ·Sarah A. Birken, Linda K. Ko, Mary Wangen, (unknown), Miriam Bender, (unknown), Mimi Choy-Brown, (unknown), Jennifer Leeman	6
15	Applying Theory to Explain the Influence of Factors External to an Organization on the Implementation of an Evidence-Based Intervention 2022 ·Frontiers in Health Services ·Jennifer Leeman, Mary Wangen, Michelle C. Kegler, Matthew Lee, Meghan C. O’Leary, Linda K. Ko, María E. Fernández, Sarah A. Birken	4
16	Using Cognitive Interviewing to Design Interventions for Implementation in Oncology Settings 2021 ·Nursing Research ·Rachel Hirschey, (unknown), Mary Wangen, Ashley Leak Bryant, Stephanie B. Wheeler, (unknown), Jennifer Leeman	4
17	Understanding quality improvement collaboratives through an implementation science lens 2019 ·Preventive Medicine ·Catherine L. Rohweder, Mary Wangen, (unknown), (unknown), (unknown), (unknown), Heather M. Brandt, Jennifer Leeman	22
18	Advancing the use of organization theory in implementation science 2019 ·Preventive Medicine ·Jennifer Leeman, Bárbara Baquero, Miriam Bender, Mimi Choy-Brown, Linda K. Ko, Per Nilsén, Mary Wangen, Sarah A. Birken	28
19	Implementation strategies to promote community-engaged efforts to counter tobacco marketing at the point of sale 2017 ·Translational Behavioral Medicine ·Jennifer Leeman, Allison Myers, (unknown), Mary Wangen, Tara L. Queen	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact